NewAmsterdam Pharma (NAMS) EBITDA Margin Growth (1y) (2024 - 2026)
NewAmsterdam Pharma (NAMS) EBITDA Margin Growth (1y) (2024 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
NewAmsterdam Pharma |
3.63 Bn |
3.63 Bn |
- |
-28,386.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-28,386.00 |
| Dec 31, 2025 |
-23.29 Mn |
| Sep 30, 2025 |
-2.05 Mn |
| Jun 30, 2025 |
162,033.00 |
| Mar 31, 2025 |
536,445.00 |
| Dec 31, 2024 |
544,240.00 |
| Sep 30, 2024 |
154,543.00 |
| Jun 30, 2024 |
51,853.00 |
| Mar 31, 2024 |
-620,592.00 |
